시장보고서
상품코드
1703202

세계의 선천성 심질환용 디바이스 시장 보고서(2025년)

Congenital Heart Defect Devices Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

선천성 심장질환용 의료기기 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 성장률(CAGR) 7.2%로 41억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 임상시험 증가, 노인 인구의 급증, 선천성 심장병 유병률 증가, 정부 지원 및 자금 지원 증가, 전문 의료 센터 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 기술 발전, 디지털 헬스 기술, 맞춤형 의료, 3D 프린팅 기술, 웨어러블 기기 등을 꼽을 수 있습니다.

선천성 심장병 장비 시장의 성장은 최소 침습 수술 증가에 의해 주도될 것으로 예상됩니다. 저침습 수술은 외상을 최소화하고 회복을 개선하기 위해 특수 툴와 기술을 사용하여 작은 절개나 자연적 신체 구멍을 통해 수술을 시행하는 것을 말합니다. 최소침습 수술 증가 요인으로는 기술 발전, 최소 침습적 치료법에 대한 환자 선호도, 수술 기술 향상, 회복 시간 및 합병증 감소로 인한 이점 등이 있습니다. 선천성 심장질환용 장비는 더 작은 절개와 카테터를 이용한 접근을 통해 심장 이상을 진단, 치료, 관리할 수 있게 함으로써 이러한 시술에서 중요한 역할을 하고 있습니다. 예를 들어 미국 성형외과학회(ASPS)에 따르면 2022년 미국에서 미용 목적으로 시행된 최소침습 수술은 2,367만 2,269건으로 전년 대비 7% 증가했습니다. 이러한 최소침습수술 증가는 결과적으로 선천성 심장질환 기기 시장을 촉진하고 있습니다.

선천성 심장질환(CHD) 기기 시장의 주요 기업이 혁신적인 솔루션을 개발하기 위해 전략적 파트너십을 체결하는 사례가 늘고 있습니다. 이러한 파트너십은 자원과 전문지식을 결합하고, 연구개발 노력을 강화하고, 시장 개발을 확대하며, 상업화 과정을 가속화함으로써 CHD 기기 분야의 기업을 돕고 있습니다. 이러한 협력 관계는 혁신을 촉진하고 산업 성장에 기여합니다. 예를 들어 2024년 5월 인도의 제조 회사인 SMT(Sahajanand Medical Technologies Pvt Ltd)는 순환기 분야의 환자 치료를 개선하기 위해 인도의 MedTech 기업인 HeartX와 파트너십을 체결했습니다. 이번 제휴를 통해 사하잔드 메디컬 테크놀러지스(SMT)는 JOVE VB 스텐트 등 HeartX의 최첨단 솔루션을 도입하여 CHD 시장에서의 입지를 강화할 예정입니다. 이번 제휴를 통해 SMT는 치료 효과를 높이고, 시술을 간소화하며, 환자의 예후를 개선하는 첨단 CHD 기기를 제공할 수 있게 되었습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계 선천성 심질환용 디바이스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 용도 산업의 분석
  • 세계의 선천성 심질환용 디바이스 시장 : 성장률 분석
  • 세계의 선천성 심질환용 디바이스 시장 실적 : 규모와 성장, 2019-2024
  • 세계의 선천성 심질환용 디바이스 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계 선천성 심질환용 디바이스 TAM(Total Addressable Market)

제6장 시장 세분화

  • 세계의 선천성 심질환용 디바이스 시장 : 디바이스 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 카테터
  • 페이스메이커
  • 단강 페이스메이커
  • 듀얼 챔버 페이스메이커
  • 양실 페이스메이커
  • 리드리스 페이스메이커
  • 이식형 제세동기
  • 양실 디바이스
  • 이식형 심장 루프 리코더
  • 기타 디바이스 유형
  • 세계의 선천성 심질환용 디바이스 시장 : 결함의 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 심방중격결손증
  • 심실중격결손증
  • 방중격결손증
  • 삼첨판 폐쇄증
  • 동맥간
  • 기타 결함의 유형
  • 세계의 선천성 심질환용 디바이스 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 병원
  • 전문 클리닉
  • 학술 조사기관
  • 기타 최종사용자
  • 세계의 선천성 심질환용 디바이스 시장, 카테터의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 풍선 카테터
  • 진단용 카테터
  • 가이드 카테터
  • 세계의 선천성 심질환용 디바이스 시장, 페이스메이커의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 단강 페이스메이커
  • 듀얼 챔버 페이스메이커
  • 양실 페이스메이커
  • 리드리스 페이스메이커
  • 세계의 선천성 심질환용 디바이스 시장, 이식형 제세동기의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 싱글 챔버 ICD
  • 듀얼 챔버 ICD
  • 피하 ICD
  • 세계의 선천성 심질환용 디바이스 시장, 양심실 디바이스의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • Crt-P(심장재동기 요법 페이스메이커)
  • Crt-D(심장재동기 요법 제세동기)
  • 세계의 선천성 심질환용 디바이스 시장, 이식형 심전도 루프 리코더의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 기존 이식형 루프 리코더
  • 피하 이식형 루프 리코더
  • 세계의 선천성 심질환용 디바이스 시장, 기타 디바이스 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 경카테터 심장판막
  • 심실 보조 기기(VADS)

제7장 지역별·국가별 분석

  • 세계의 선천성 심질환용 디바이스 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 세계의 선천성 심질환용 디바이스 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 선천성 심질환용 디바이스 시장 : 경쟁 구도
  • 선천성 심질환용 디바이스 시장 : 기업 개요
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

  • Medtronic plc.
  • Philips Healthcare
  • Boston Scientific Corporation
  • W. L. Gore & Associates Inc.
  • Masimo Corporation
  • Lepu Medical Technology(Beijing) Co. Ltd.
  • MicroPort Scientific Corporation
  • Stereotaxis Inc.
  • Berlin Heart GmbH
  • Ventracor Limited
  • Syncardia Systems LLC
  • On-X Life Technologies Inc.
  • Occlutech Holding AG
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Response Biomedical Corporation

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • 선천성 심질환용 디바이스 시장 2029 : 새로운 기회를 제공하는 국가
  • 선천성 심질환용 디바이스 시장 2029 : 새로운 기회를 제공하는 부문
  • 선천성 심질환용 디바이스 시장 2029 : 성장 전략
    • 시장 동향에 기반한 전략
    • 경쟁의 전략

제36장 부록

KSA 25.05.08

Congenital heart defect devices are specialized medical instruments and implants designed to address and manage heart abnormalities present from birth. These devices are used to diagnose, treat, and support the heart's function in individuals with congenital heart defects, aiming to restore normal blood flow and enhance cardiac performance.

The primary types of congenital heart defect devices include catheters, pacemakers (single-chamber, dual-chamber, biventricular, and leadless), implantable cardioverter defibrillators, biventricular devices, and implanted cardiac loop recorders. Catheters are slender, flexible tubes inserted into the body for various functions such as diagnostic, therapeutic, or monitoring purposes. These devices are used for different types of congenital defects, including ventricular septal defect, atrioventricular septal defect, tricuspid atresia, truncus arteriosus, and others. They are employed by hospitals, specialty clinics, academic and research institutions, and other healthcare settings.

The congenital heart defect devices market research report is one of a series of new reports from The Business Research Company that provides congenital heart defect devices market statistics, including congenital heart defect devices industry global market size, regional shares, competitors with a congenital heart defect devices market share, detailed congenital heart defect devices market segments, market trends and opportunities, and any further data you may need to thrive in the Congenital heart defect devices industry. This Congenital heart defect devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart defect devices market size has grown strongly in recent years. It will grow from $2.91 billion in 2024 to $3.13 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to growth in healthcare awareness campaigns, increasing number of heart defect screening programs, growth in medical device regulations, increasing prevalence of congenital heart defect, and increase in the risk of organ failure.

The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing clinical trials, a surge in the geriatric population, an increasing prevalence of congenital heart defects, rising government support and funding, and an increasing number of specialized medical centers. Major trends in the forecast period include technological advancements, digital health technologies, personalized medicine, 3D printing technology, and wearable devices.

The growth of the congenital heart defect device market is anticipated to be driven by the rising number of minimally invasive procedures. These procedures involve performing surgeries through small incisions or natural body openings, using specialized tools and techniques to minimize trauma and improve recovery. Factors contributing to the increase in minimally invasive procedures include technological advancements, patient preference for less invasive treatments, enhanced surgical techniques, and the advantages of reduced recovery times and complications. Congenital heart defect devices play a crucial role in these procedures by enabling the diagnosis, treatment, and management of heart abnormalities through smaller incisions or catheter-based approaches. For example, according to the American Society of Plastic Surgeons (ASPS), 23,672,269 cosmetic minimally invasive procedures were performed in the United States in 2022, marking a 7% increase from previous years. This rise in minimally invasive procedures is consequently boosting the congenital heart defect device market.

Major players in the congenital heart defect (CHD) devices market are increasingly forming strategic partnerships to develop innovative solutions. These partnerships help companies in the CHD devices sector by combining resources and expertise, enhancing research and development efforts, expanding market reach, and accelerating the commercialization process. Such collaborations foster innovation and contribute to industry growth. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, entered into a partnership with HeartX, an India-based MedTech firm, to improve patient care in the cardiovascular sector. Through this collaboration, Sahajanand Medical Technologies (SMT) strengthens its presence in the CHD market by incorporating HeartX's cutting-edge solutions, such as the JOVE VB Stent. This alliance enables SMT to provide advanced CHD devices that improve treatment effectiveness, simplify procedures, and enhance patient outcomes.

In June 2023, Translumina Therapeutics LLP, an India-based cardiovascular device manufacturer, acquired Wellinq Group Company for an undisclosed sum. This acquisition aims to broaden Translumina's cardiovascular and endovascular solutions portfolio and strengthen its market presence in the Netherlands by integrating Blue Medical Devices' innovative technologies and expertise. Wellinq Group Company, based in the Netherlands, specializes in developing and manufacturing products for treating congenital heart defects.

Major companies operating in the congenital heart defect devices market are Pfizer Inc., Johnson & Johnson, AstraZeneca plc., Abbott Laboratories, GlaxoSmithKline plc., Medtronic plc., Philips Healthcare, Boston Scientific Corporation, W. L. Gore & Associates Inc., Masimo Corporation, Lepu Medical Technology (Beijing) Co. Ltd., MicroPort Scientific Corporation, Stereotaxis Inc., Berlin Heart GmbH, Ventracor Limited, Syncardia Systems LLC, On-X Life Technologies Inc., Occlutech Holding AG, Sahajanand Medical Technologies Pvt. Ltd., Response Biomedical Corporation, Xeltis AG, Procyrion Inc., Heartstitch Inc., Cardia Inc., OSYPKA Medical GmbH

North America was the largest region in the congenital heart defect devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart defect devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congenital heart defect devices market consists of sales of septal occluders, heart valves, patent ductus arteriosus (PDA) devices, and bioprosthetic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Defect Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congenital heart defect devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart defect devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The congenital heart defect devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Catheters; Pacemakers; Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers; Implantable Cardioverter Defibrillators; Biventricular Devices; Implanted Cardiac Loop Recorders; Other Device Types
  • 2) By Defect Type: Atrial Septal Defect; Ventricular Septal Defect; Atrioventricular Septal Defect; Tricuspid Atresia; Truncus Arteriosus; Other Defect Types
  • 3) By End user: Hospitals; Specialty Clinics; Academic And Research Institute; Other End Users
  • Subsegments:
  • 1) By Catheters: Balloon Catheters; Diagnostic Catheters; Guiding Catheters
  • 2) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers
  • 3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds; Dual-Chamber Icds; Subcutaneous Icds
  • 4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers); Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders; Subcutaneous Implantable Loop Recorders
  • 6) By Other Device Types: Transcatheter Heart Valves; Ventricular Assist Devices (VADS)
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AstraZeneca plc.; Abbott Laboratories; GlaxoSmithKline plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Congenital Heart Defect Devices Market Characteristics

3. Congenital Heart Defect Devices Market Trends And Strategies

4. Congenital Heart Defect Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Congenital Heart Defect Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Congenital Heart Defect Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Congenital Heart Defect Devices Market Growth Rate Analysis
  • 5.4. Global Congenital Heart Defect Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Congenital Heart Defect Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Congenital Heart Defect Devices Total Addressable Market (TAM)

6. Congenital Heart Defect Devices Market Segmentation

  • 6.1. Global Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheters
  • Pacemakers
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers
  • Leadless Pacemakers
  • Implantable Cardioverter Defibrillators
  • Biventricular Devices
  • Implanted Cardiac Loop Recorders
  • Other Device Types
  • 6.2. Global Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect
  • Ventricular Septal Defect
  • Atrioventricular Septal Defect
  • Tricuspid Atresia
  • Truncus Arteriosus
  • Other Defect Types
  • 6.3. Global Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Academic And Research Institute
  • Other End Users
  • 6.4. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Catheters
  • Diagnostic Catheters
  • Guiding Catheters
  • 6.5. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers
  • Leadless Pacemakers
  • 6.6. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Icds
  • Dual-Chamber Icds
  • Subcutaneous Icds
  • 6.7. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crt-P (Cardiac Resynchronization Therapy Pacemakers)
  • Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 6.8. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implanted Cardiac Loop Recorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Implantable Loop Recorders
  • Subcutaneous Implantable Loop Recorders
  • 6.9. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Heart Valves
  • Ventricular Assist Devices (VADS)

7. Congenital Heart Defect Devices Market Regional And Country Analysis

  • 7.1. Global Congenital Heart Defect Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Congenital Heart Defect Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congenital Heart Defect Devices Market

  • 8.1. Asia-Pacific Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congenital Heart Defect Devices Market

  • 9.1. China Congenital Heart Defect Devices Market Overview
  • 9.2. China Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congenital Heart Defect Devices Market

  • 10.1. India Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congenital Heart Defect Devices Market

  • 11.1. Japan Congenital Heart Defect Devices Market Overview
  • 11.2. Japan Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congenital Heart Defect Devices Market

  • 12.1. Australia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congenital Heart Defect Devices Market

  • 13.1. Indonesia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congenital Heart Defect Devices Market

  • 14.1. South Korea Congenital Heart Defect Devices Market Overview
  • 14.2. South Korea Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congenital Heart Defect Devices Market

  • 15.1. Western Europe Congenital Heart Defect Devices Market Overview
  • 15.2. Western Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congenital Heart Defect Devices Market

  • 16.1. UK Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congenital Heart Defect Devices Market

  • 17.1. Germany Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congenital Heart Defect Devices Market

  • 18.1. France Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congenital Heart Defect Devices Market

  • 19.1. Italy Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congenital Heart Defect Devices Market

  • 20.1. Spain Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congenital Heart Defect Devices Market

  • 21.1. Eastern Europe Congenital Heart Defect Devices Market Overview
  • 21.2. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congenital Heart Defect Devices Market

  • 22.1. Russia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congenital Heart Defect Devices Market

  • 23.1. North America Congenital Heart Defect Devices Market Overview
  • 23.2. North America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congenital Heart Defect Devices Market

  • 24.1. USA Congenital Heart Defect Devices Market Overview
  • 24.2. USA Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congenital Heart Defect Devices Market

  • 25.1. Canada Congenital Heart Defect Devices Market Overview
  • 25.2. Canada Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congenital Heart Defect Devices Market

  • 26.1. South America Congenital Heart Defect Devices Market Overview
  • 26.2. South America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congenital Heart Defect Devices Market

  • 27.1. Brazil Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congenital Heart Defect Devices Market

  • 28.1. Middle East Congenital Heart Defect Devices Market Overview
  • 28.2. Middle East Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congenital Heart Defect Devices Market

  • 29.1. Africa Congenital Heart Defect Devices Market Overview
  • 29.2. Africa Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congenital Heart Defect Devices Market Competitive Landscape And Company Profiles

  • 30.1. Congenital Heart Defect Devices Market Competitive Landscape
  • 30.2. Congenital Heart Defect Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

31. Congenital Heart Defect Devices Market Other Major And Innovative Companies

  • 31.1. Medtronic plc.
  • 31.2. Philips Healthcare
  • 31.3. Boston Scientific Corporation
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. Masimo Corporation
  • 31.6. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Stereotaxis Inc.
  • 31.9. Berlin Heart GmbH
  • 31.10. Ventracor Limited
  • 31.11. Syncardia Systems LLC
  • 31.12. On-X Life Technologies Inc.
  • 31.13. Occlutech Holding AG
  • 31.14. Sahajanand Medical Technologies Pvt. Ltd.
  • 31.15. Response Biomedical Corporation

32. Global Congenital Heart Defect Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congenital Heart Defect Devices Market

34. Recent Developments In The Congenital Heart Defect Devices Market

35. Congenital Heart Defect Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Congenital Heart Defect Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Congenital Heart Defect Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Congenital Heart Defect Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제